Medication-assisted treatment (MAT) for kratom dependence

At a glance: MAT for kratom

Key Takeaways

• MAT is medication plus support, not medication alone. The medication addresses the physical dependence; counseling, health coaching, and peer support address the patterns around it.
• It applies to kratom because the biology matches. Kratom acts on mu-opioid receptors, producing tolerance, dependence, and withdrawal through the same mechanisms as opioids. MAT was designed for exactly that pattern.
• Buprenorphine is the practical option for kratom. Published case series document successful treatment, including in people whose only substance was kratom.
• It is not trading one addiction for another. At an appropriate dose, buprenorphine stabilizes the opioid receptor system without producing highs, sedation, or the dose-chasing cycle that characterizes active dependence.
• Treatment is available from home. Bicycle Health provides telehealth MAT for kratom dependence, including same-day evaluation in most states.

What MAT is and why it applies to kratom

SAMHSA defines medication-assisted treatment as the use of FDA-approved medications, in combination with counseling and behavioral therapies, to provide a comprehensive approach to treating substance use disorders. The three medications approved for opioid use disorder are buprenorphine, methadone, and naltrexone. All three have been used or studied in kratom contexts; in clinical practice, buprenorphine is by far the most commonly used.

Kratom's alkaloids, mitragynine and 7-hydroxymitragynine, bind mu-opioid receptors. With regular use, the brain adapts to their presence through neuroadaptation. When kratom is stopped, the adaptation persists while the drug clears, producing opioid-pattern withdrawal. Buprenorphine stabilizes the same receptor system, which is why it prevents withdrawal and reduces cravings for people dependent on kratom just as it does for people dependent on heroin or oxycodone.

This is not a repurposed medication applied to an unrelated problem. It is the correct pharmacological match for opioid-receptor dependence, regardless of which substance drove that dependence.

A note on terminology: Many clinicians now prefer "medications for opioid use disorder" (MOUD) over the older "MAT" framing because it reflects that the medication is the treatment, not just an assist. Both terms refer to the same clinical approach and appear throughout published guidance. This article uses both, as "MAT" is still the more commonly searched term.

How MAT compares to quitting without medication

The clearest way to understand what MAT adds is to look at the alternative.

Stopping kratom without medication means enduring full-intensity withdrawal, which peaks around days 2 to 4. During that window, the pull back to using is powerful because using brings immediate relief from every symptom. For people with mild, short-term leaf use, this is feasible. For people using daily, using concentrated 7-OH, or who have already tried to stop and not been able to hold it, cold turkey is poorly matched to the biology of dependence.

Buprenorphine changes that equation at the receptor level. It stabilizes the mu-opioid receptors that kratom was activating, so the acute withdrawal phase largely does not occur. The person is not white-knuckling a chemical adaptation; the chemical adaptation is being addressed directly.

In the largest published case series (Broyan et al., 2022, 28 patients), 71% remained in outpatient treatment at follow-up averaging 11 months, and 82% tested negative for mitragynine at 8 to 12 weeks. That retention and abstinence picture is substantially better than what unsupported cold turkey produces, where the relapse rate during the acute withdrawal window is high.

For the full evidence summary, see Does Suboxone Work for Kratom Addiction?. For a three-way comparison of options, see Quitting Kratom Cold Turkey vs. Tapering vs. Suboxone.

How MAT for kratom works at Bicycle Health

The Bicycle Health model has four components, all accessible via telehealth:

1. Enrollment and assessment. The process begins with a free call with an enrollment coordinator. The coordinator learns about your experience with kratom or 7-OH, your health history, and your goals. This call is confidential. It gives you a chance to ask questions and confirm that telehealth MAT is the right fit before committing to anything.

2. Provider evaluation and treatment plan. You then meet with a licensed medical provider by video. The provider reviews your kratom or 7-OH use in detail, conducts a clinical evaluation, and works with you to develop a personalized treatment plan. Most patients who are appropriate candidates receive a buprenorphine/naloxone prescription during or shortly after this first provider visit.

3. Prescription and induction. The prescription is sent electronically to a pharmacy near you. Your provider gives you guidance on induction timing, specifically, when to take your first dose relative to your last kratom or 7-OH use to avoid precipitated withdrawal. Follow-up telehealth visits are scheduled weekly, biweekly, or monthly depending on where you are in treatment, with dose adjusted based on your response. For the induction timing detail, see How to Switch From Kratom to Suboxone.

4. Behavioral health supports. Bicycle Health pairs medication with behavioral health resources, including online support groups and health coaching. Medical providers can also address co-occurring conditions such as depression and anxiety. Research consistently shows that combining medication with behavioral health support produces better outcomes than either alone.

This entire process happens from home, without clinical visits, clinic commutes, or daily dispensing trips. For people managing jobs, families, and the logistics of daily life, that accessibility is often the difference between getting help and not.

Insurance and cost

Many insurance plans, including most major private insurance and Medicaid, cover buprenorphine treatment for opioid use disorder. Bicycle Health accepts most major insurance and works directly with Medicaid in most states where it operates.

If you do not have insurance or your plan does not cover treatment, cash-pay options are available. Generic buprenorphine/naloxone is substantially less expensive than the brand-name Suboxone and is clinically equivalent; it is available at most major pharmacies.

One comparison worth considering: an escalating kratom or 7-OH habit has its own monthly cost, and that cost tends to rise as tolerance increases. Many patients in treatment find their monthly medication cost is less than what they were spending on products. The financial comparison, alongside the health and quality-of-life picture, often looks very different once treatment stabilizes things.

For current coverage details and pricing, see the insurance and pricing page.

Frequently Asked Questions

Is MAT just swapping one addiction for another?

No. At an appropriate dose, buprenorphine stabilizes the opioid receptor system without producing sedation, intoxication, or the euphoria associated with active opioid use. SAMHSA is explicit on this point: people on a proper maintenance dose function normally. The experience is closer to managing a chronic condition with medication than to substituting one high for another. The contrast with active kratom dependence is significant: dependence means chasing doses, riding highs and lows, and organizing the day around supply. MAT means a stable baseline and a life no longer structured around the next dose.

How long will I be on buprenorphine for kratom?

Treatment duration is individualized. There is no fixed endpoint you are expected to hit, and no clinical guideline defines how long someone must stay or must stop by. Some people taper off buprenorphine after stabilizing, over a period of months with clinical supervision. Others remain on maintenance for a year or more. Research on OUD treatment consistently shows that longer duration is associated with better outcomes. Your prescriber guides this plan based on how you are doing and what your goals are.

Do I qualify for MAT if kratom is all I use?

Yes. People whose only substance is kratom are treated with buprenorphine for kratom use disorder. Published case series include patients with no other opioid history. Whether you qualify is determined by a clinical evaluation, not by which substances you have used. For the full answer, see "I Only Use Kratom" — Why That Still Qualifies for MAT.

Will buprenorphine show on a drug test at work?

Buprenorphine is not a target analyte on the standard DOT 5-panel or most workplace drug panels. It does not cause a positive result on the opioid portion of standard screens. Some expanded employer panels do include buprenorphine as an add-on test; if it appears, a valid prescription documents legal use. For DOT-regulated roles, separate considerations apply. See Does 7-OH Show Up on a DOT Drug Test? for the full detail.

Can I get MAT for kratom through telehealth?

Yes. Bicycle Health provides telehealth MAT for kratom and 7-OH dependence in most U.S. states. Under current federal rules, buprenorphine can be prescribed via telehealth without a prior in-person visit. Evaluations happen by video, prescriptions go to your local pharmacy, and follow-up visits are online. Many patients are seen the same day they reach out. See Can You Get Suboxone for Kratom Addiction Online? for the regulatory detail.